This printed article is located at https://investor.ouehealthcare.com/news.html
| Announcement Title | Change - Announcement of Cessation |
| Date & Time of Broadcast | Mar 25, 2024 17:31 |
| Status | New |
| Announcement Sub Title | RESIGNATION OF NON-INDEPENDENT AND NON-EXECUTIVE DIRECTOR |
| Announcement Reference | SG240325OTHRAIEG |
| Submitted By (Co./ Ind. Name) | Mr Yet Kum Meng |
| Designation | Chief Executive Officer and Executive Director |
| Description (Please provide a detailed description of the event in the box below) | Resignation of Mr. Tetsuya Fujimoto as a Non-Independent and Non-Executive Director. This announcement has been reviewed by the Company's sponsor, PrimePartners Corporate Finance Pte. Ltd. (the "Sponsor"). It has not been examined or approved by the Singapore Exchange Securities Trading Limited (the "Exchange") and the Exchange assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement. The contact person for the Sponsor is Ms. Foo Jien Jieng, 16 Collyer Quay, #10-00 Collyer Quay Centre, Singapore 049318, sponsorship@ppcf.com.sg. |
| Additional Details | |
| Name Of Person | Tetsuya Fujimoto |
| Age | 56 |
| Is effective date of cessation known? | Yes |
| If yes, please provide the date | 09/04/2024 |
| Detailed Reason (s) for cessation | Mr. Tetsuya Fujimoto ("Mr. Fujimoto") had, on 25 March 2024, tendered his resignation as a Non-Independent and Non-Executive Director of OUE Healthcare Limited (the "Company") with effect from 9 April 2024 to return to Japan and assume other responsibilities within the ITOCHU Corporation. After having interviewed Mr. Fujimoto and to the best of its knowledge, the Company's Sponsor, PrimePartners Corporate Finance Pte. Ltd., is satisfied that save as disclosed in this announcement, there are no other material reasons for the stepping down of Mr. Fujimoto as a Non-Independent and Non-Executive Director of the Company. |
| Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting? | No |
| Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer? | No |
| Any other relevant information to be provided to shareholders of the listed issuer? | No |
| Date of Appointment to current position | 01/04/2022 |
| Does the AC have a minimum of 3 members (taking into account this cessation)? | Yes |
| Number of Independent Directors currently resident in Singapore (taking into account this cessation) | 3 |
| Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months | 2 |
| Job Title (e.g. Lead ID, AC Chairman, AC Member etc.) | Non-Independent and Non-Executive Director, a member of the Nominating and Remuneration Committee of the Company |
| Role and responsibilities | The role and responsibilities as a Non-Independent and Non-Executive Director, a member of the Nominating and Remuneration Committee of the Company |
| Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries | No |
| Shareholding interest in the listed issuer and its subsidiaries? | No |
| Past (for the last 5 years) | Nil |
| Present | OUE Healthcare Limited |